ClearPoint Neuro, Together with its Partner Clinical Laserthermia Systems, Announces FDA Submission to Expand the Labeling of ClearPoint Prism(R) to Include 1.5 T MRI

Stock Information for ClearPoint Neuro, Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About ClearPoint Neuro, Inc.

ClearPoint Neuro Completes Acquisition of IRRAS
ClearPoint Neuro Reports Third Quarter 2025 Results
ClearPoint Neuro Announces Agreement to Acquire IRRAS
ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2025
ClearPoint Neuro Announces Promising Results from Brain Tumor Laser Therapy Study to be Presented at the CNS Annual Meeting in Los Angeles
ClearPoint Neuro Announces Expanded International Clearances for Key Therapy Delivery Product; Now Totaling 34 Countries Worldwide
ClearPoint Neuro Announces Development and Demonstration of the Company's Proprietary Robotic Neuro-Navigation System
ClearPoint Neuro Announces the Appointment of Dr. Paul Larson as Chief Medical Officer

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.